RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Novartis AG

A collection of news and information related to Novartis AG published by this site and its partners.

Top Novartis AG Articles

Displaying items 25-36
  • Fighting diseases with genetic therapy

     Fighting diseases with genetic therapy
    Genes make us who we are — in sickness and in health. We get our genetic makeup from our parents, of course, but in the future, we might be getting genes from our doctors too. Imagine your doctor promising to cure your cancer or heart disease by...
  • More evidence hormone patch is safer than pills

    More evidence hormone patch is safer than pills
    NEW YORK (Reuters Health) - A new study adds to evidence that skin patches offer a safer alternative to pills for women who want to treat their menopausal symptoms with hormones. The study, of 54,000 women who used hormone replacement therapy (HRT),...
  • Tailored breast cancer drugs in focus at cancer meet

    Tailored breast cancer drugs in focus at cancer meet
    ZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis. Roche's T-DM1 and Novartis's Afinitor...
  • Roche bone drug eases pain in prostate cancer trial

    Roche bone drug eases pain in prostate cancer trial
    STOCKHOLM (Reuters) - Roche's bone strengthening drug Boniva is as good for pain relief as single dose radiotherapy in patients whose prostate cancer has spread to their bones, according to data from a late-stage trial released on Sunday. Trial...
  • Novartis drug may help older breast cancer patients

    Novartis drug may help older breast cancer patients
    STOCKHOLM (Reuters) - Novartis's bone drug Zometa extended survival in older breast cancer patients but failed to improve disease-free survival among younger women patients in a large-scale clinical trial, researchers said on Sunday. Detailed data...
  • Study: ADHD is a genetic disorder

    Study: ADHD is a genetic disorder
    British scientists have found the first direct evidence that attention-deficit/hyperactivity disorder is a genetic disorder and say their research could eventually lead to better treatments for the condition. Researchers who scanned the gene maps of more...
  • FDA approves first oral drug to slow multiple sclerosis progression

    A failed anti-rejection drug got a new purpose and a new lease on commercial life Wednesday as the Food and Drug Administration approved the medication fingolimod -- to be marketed as Gilenya -- to slow the progression of disability in multiple...
  • Scientists see AIDS vaccine within reach after decades

    Scientists see AIDS vaccine within reach after decades
    CHICAGO (Reuters) - At an ill-fated press conference in 1984, U.S. Health and Human Services Secretary Margaret Heckler boldly predicted an effective AIDS vaccine would be available within just two years. But a string of failed attempts - punctuated by a...
  • Exercise tied to lower risk of psoriasis: study

    Exercise tied to lower risk of psoriasis: study
    NEW YORK (Reuters Health) - Results from a large U.S. study suggest women who regularly exercise vigorously, including runners and aerobics buffs, may be less likely to get psoriasis than less-active women. Researchers have known that people who are...
  • Asthma drugs may increase attacks in kids: report

    Asthma drugs may increase attacks in kids: report
    NEW YORK (Reuters Health) - One class of drugs used to prevent wheezing and shortness of breath in people with asthma may increase kids' risk of being hospitalized for an asthma attack, according to a new analysis from the U.S. Food and Drug...
  • Pharma cases drive U.S. Attorney's collections

     
    The U.S. Attorney’s Office for the Eastern District of Pennsylvania announced Thursday that it has collected nearly $4.4 billion in civil penalties since 2004. While the rules for disbursing those payments between state and federal agencies make it...
  • We want drama! ABC soap fans rally to keep Erica Kane and her daytime friends on the air

     
    Like sands through the hourglass, daytime soap operas are falling off the TV grid. The recent demise started in 2007 with the cancellation of “Passions” on NBC (and later on DirecTV). Two years later, CBS nixed “The Guiding Light”...